Company profile
Cerus Endovascular
| Transforming Interventional Neuroradiology | Contour Neurovascular System | NEQSTENT | Intra-saccular flow diversion Cerus | Cerus Endovascular |
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
SH19 | Transaction MzQ0NDg4NjgxNmFkaXF6a2N4 | Paper/PDF filed
Published 27 Nov 2024 11:15
RESOLUTIONS | Transaction WURHTzREQ0NhZGlxemtjeA | Paper/PDF filed
Published 27 Nov 2024 11:04
CAP-SS | Transaction MzQ0NDg4NjQzOWFkaXF6a2N4 | Paper/PDF filed
Published 27 Nov 2024 10:52
SH20 | Transaction MzQ0NDg4NjQ3MWFkaXF6a2N4 | Paper/PDF filed
Published 27 Nov 2024 10:50
AP01 | Transaction MzQ0MzU0MDg0OWFkaXF6a2N4
Published 15 Nov 2024 09:53
TM01 | Transaction MzQ0MzU0MDg0OGFkaXF6a2N4
Published 15 Nov 2024 09:53
TM01 | Transaction MzQ0MzU0MDg1MGFkaXF6a2N4
Published 15 Nov 2024 09:53
Company registered at Companies House
1 Sep 2014 to 29 Feb 2016
Intracranial Cerebral Aneurysm [ICA], the ballooning of a blood vessel caused by weakness in the wall or vein of an artery, is a devastating condition for patients and their families and affects around 5% of the UK population, with rupture occurring in 1 in 100,000 people each year. When an ICA ruptures there is a 30% chance of death, and 20-30% chance of...
